Article Text

Download PDFPDF

235 Borderline ovarian tumors (BOT): Clinico-pathological features, oncological and fertility outcomes
Free
  1. U Chishti,
  2. AB Aziz,
  3. H Aziz and
  4. N Sikander
  1. Aga Khan University Hospital, Obstetrics and Gynaecology, Karachi, Pakistan

Abstract

Introduction/Background*BOT are heterogeneous subset of epithelial ovarian tumors, predominantly diagnosed at earlier stages with overall excellent prognosis. Though less but the risk of recurrence remains a matter of concern. In this study, we analyzed the clinicopathological variables, oncological and fertility outcomes of BOT.

Methodology This was a retrospective, cross-sectional study conducted at the department of Obstetrics & Gynaecology, Aga khan hospital Karachi from 2002 to 2018.

Result(s)*A total of 73 patients with BOT were included with a mean age of 43 years. Thirty five (48%) patients had fertility sparing surgery (FSS) while 38(52%) underwent debulking surgery. Pre-operative CA-125 IU level was 125 in FSS group and 67 in debulking group.

Laparotomy was the common surgical approach in both the groups with Only 5 (14%) patients in FSS group had minimal access surgery. Only 3 patients (8%) had residual disease in debulking group.

Majority of patients in both FSS and debulking groups had FIGO stage 1 disease 34 (97%) and 34(89%) respectively. The serous histological type was common in both the groups while unilateral lesion more prevalent in the FSS group (83% vs. 68%).

Recurrence was reported in 3(8.6%) patient in FSS group, while 1 (2.6%) in debulking group. The average time to recurrence was 31 months (11-51 months). Among the 4 recurrences 3 had either capsule breach or surface disease and 3 had mucinous and 1 was serous histotype. Among the recurrences 3 were in stage 1 and one in stage 3C. Cytology was positive in 4(11.4%) patients in FSS group and 8(21%) patients in debulking group but it did not have any impact on recurrence. Three patients (8.5%) conceived in FSS and had live births. Surgical approach was laparotomy in these patients and all of them had stage 1A disease.

Conclusion*BOT have an excellent prognosis. Relapses occur late in the trajectory of disease and hence regular follow-ups are important. Recurrences are independent of age and are more common in mucinous tumors with surface disease and can occur even in early stages.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.